Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1987 Nov;77(11):1427–1430. doi: 10.2105/ajph.77.11.1427

Contraceptive needs and practices among women attending an inner-city STD clinic.

D M Upchurch 1, M Y Farmer 1, D Glasser 1, E W Hook 3rd 1
PMCID: PMC1647103  PMID: 3661795

Abstract

To assess the potential need, interest, and benefits of provision of contraceptive services in sexually transmitted disease (STD) clinics, we surveyed 516 women attending an inner-city STD clinic regarding contraceptive and sexual practices, STD prevalence, knowledge of contraceptive-related STD prophylaxis, and interest in contraceptive services within the STD clinic setting. The study population was at high risk for unintended pregnancy and STDs; at time of interview 46 per cent of women were not contracepting and 59 per cent were treated for STD or STD exposure. Two-thirds of women had at least one prior pregnancy and 50 per cent had at least one living child. Only 26 per cent of women knew that some contraceptive methods may reduce the risk of STD acquisition; however, 62 per cent expressed interest in contraceptive methods which would reduce their risk of STD acquisition. This study suggests that provision of contraceptive services in STD clinic settings may address dual needs in a group at high risk for both unintended pregnancy and STD.

Full text

PDF
1427

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin H., Louv W. C., Alexander W. J. A case-control study of spermicides and gonorrhea. JAMA. 1984 Jun 1;251(21):2822–2824. [PubMed] [Google Scholar]
  2. Bachrach C. A. Contraceptive practice among American women, 1973-1982. Fam Plann Perspect. 1984 Nov-Dec;16(6):253–259. [PubMed] [Google Scholar]
  3. Barlow D. The condom and gonorrhoea. Lancet. 1977 Oct 15;2(8042):811–813. doi: 10.1016/s0140-6736(77)90737-1. [DOI] [PubMed] [Google Scholar]
  4. Berger G. S., Keith L., Moss W. Prevalence of gonorrhoea among women using various methods of contraception. Br J Vener Dis. 1975 Oct;51(5):307–309. doi: 10.1136/sti.51.5.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cates W., Jr Sexually transmitted diseases and family planning. Strange or natural bedfellows? J Reprod Med. 1984 May;29(5):317–322. [PubMed] [Google Scholar]
  6. Cole C. H., Lacher T. G., Bailey J. C., Fairclough D. L. Vaginal chemoprophylaxis in the reduction of reinfection in women with gonorrhoea. Clinical evaluation of the effectiveness of a vaginal contraceptive. Br J Vener Dis. 1980 Oct;56(5):314–318. doi: 10.1136/sti.56.5.314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Conant M. A., Spicer D. W., Smith C. D. Herpes simplex virus transmission: condom studies. Sex Transm Dis. 1984 Apr-Jun;11(2):94–95. doi: 10.1097/00007435-198404000-00009. [DOI] [PubMed] [Google Scholar]
  8. Hicks D. R., Martin L. S., Getchell J. P., Heath J. L., Francis D. P., McDougal J. S., Curran J. W., Voeller B. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet. 1985 Dec 21;2(8469-70):1422–1423. doi: 10.1016/s0140-6736(85)92584-x. [DOI] [PubMed] [Google Scholar]
  9. Jick H., Hannan M. T., Stergachis A., Heidrich F., Perera D. R., Rothman K. J. Vaginal spermicides and gonorrhea. JAMA. 1982 Oct 1;248(13):1619–1621. [PubMed] [Google Scholar]
  10. Kelaghan J., Rubin G. L., Ory H. W., Layde P. M. Barrier-method contraceptives and pelvic inflammatory disease. JAMA. 1982 Jul 9;248(2):184–187. [PubMed] [Google Scholar]
  11. Paavonen J., Critchlow C. W., DeRouen T., Stevens C. E., Kiviat N., Brunham R. C., Stamm W. E., Kuo C. C., Hyde K. E., Corey L. Etiology of cervical inflammation. Am J Obstet Gynecol. 1986 Mar;154(3):556–564. doi: 10.1016/0002-9378(86)90601-0. [DOI] [PubMed] [Google Scholar]
  12. Quinn R. W., O'Reilly K. R. Contraceptive practices of women attending the Sexually Transmitted Disease Clinic in Nashville, Tennessee. Sex Transm Dis. 1985 Jul-Sep;12(3):99–102. doi: 10.1097/00007435-198507000-00001. [DOI] [PubMed] [Google Scholar]
  13. Singh B., Cutler J. C., Utidjian H. M. Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease and other genital infections and contraception. II. Effect in vitro of vaginal contraceptive and non-contraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae. Br J Vener Dis. 1972 Feb;48(1):57–64. doi: 10.1136/sti.48.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Stamm W. E., Tam M., Koester M., Cles L. Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol. 1983 Apr;17(4):666–668. doi: 10.1128/jcm.17.4.666-668.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stone K. M., Grimes D. A., Magder L. S. Personal protection against sexually transmitted diseases. Am J Obstet Gynecol. 1986 Jul;155(1):180–188. doi: 10.1016/0002-9378(86)90108-0. [DOI] [PubMed] [Google Scholar]
  16. Stone K. M., Grimes D. A., Magder L. S. Primary prevention of sexually transmitted diseases. A primer for clinicians. JAMA. 1986 Apr 4;255(13):1763–1766. [PubMed] [Google Scholar]
  17. Yarber W. L. Teenage girls and venereal disease prophylaxis. Br J Vener Dis. 1977 Apr;53(2):135–139. doi: 10.1136/sti.53.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES